New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.
How is CRISPR genome editing helping harness the power of immunotherapy?
At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.
This year’s British Science Week runs from 10th – 19th March, and the theme is ‘change’.
Read our final roundup from this year’s NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.